Home | Blood, Heart and Circulation

Blood, Heart and Circulation

Heart failure accelerates male ‘menopause’

Four-fold increase of andropausal syndrome in men with heart failure ...

First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half in randomised double blind trial ... Full story

Youth with Type 2 diabetes at much higher risk for heart, kidney disease

SAN ANTONIO — The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than people who acquire Type 2 diabetes as adults. ... Full story

Death rates decline for advanced heart failure patients, but outcomes are still not ideal

UCLA study looks in detail at thousands of patients treated over last 20 years ... Full story


Data from nearly 3,000 children shows dietary exposure to certain plastics may play a hidden role in epidemic increases in childhood hypertension ... Full story

Post-approval TAVI registry shows high rates of device success at one year

One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries ... Full story

Biodegradable Orsiro stent proves non-inferior to Xience Prime drug-eluting stent for in-stent late lumen loss at nine months

Paris, France: The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent late lumen loss at nine months in the results of an imaging substudy reported at EuroPCR 2013 today. ... Full story

Swedish registry questions superiority of bivalirudin over heparin in patients undergoing PCI for NSTE-ACS

Paris, France: Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI). ... Full story

Antidepressant reduces stress-induced heart condition

By Duke Medicine News and Communications - DURHAM, N.C. – A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine. ... Full story

first back 11 12 13 14 15 16 17 18 19 20 next last total: 2269 | displaying: 181 - 190